One email a week. The research, not the hype.

We publish 226 articles on testosterone, GLP-1s, peptides and the rest of men’s health, every one sourced to the FDA label or the trial it came from. The email is what changed that week and what it means if you are on a protocol.

• What we published

  Two or three new pieces, with the finding stated up front so you can skip the ones that do not apply to you.

• What changed in the evidence

  New trial data, label updates, recalls and shortages — the things that change a decision you already made.

• What it costs

  Pricing moves across the providers and pharmacies we track, which is the number most guides leave out.

We do not sell or share your address, and the calculators stay free and ungated whether you subscribe or not.